Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical potentials of methylator phenotype in stage 4 high-risk neuroblastoma: an open challenge.

PloS one - 1 Jan 2013

Banelli Barbara, Merlo Domenico Franco, Allemanni Giorgio, Forlani Alessandra, Romani Massimo

Abstract excerpt

Approximately 20% of stage 4 high-risk neuroblastoma patients are alive and disease-free 5 years after disease onset while the remaining experience rapid and fatal progression. Numerous findings underline the prognostic role of methylation of defined target genes in neuroblastoma without taking i...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 14-3-3 Proteins
Share to Biomarkers, Tumor
Share to CpG Islands

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease-Free Survival

Share to DNA Methylation

Share to Exoribonucleases

Share to Neuroblastoma

Source

Open in PubMed Open full text

Identifiers

PMID: 23717404
DOI: 10.1371/journal.pone.0063253
PMCID: PMC3661569

Genes

SFN

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23717404-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical potentials of methylator phenotype in stage 4 high-risk neuroblastoma: an open challenge.PMID 23717404Read ↗

A pyrosequencing assay for the quantitative methylation analysis of the PCDHB gene cluster, the major factor in neuroblastoma methylator phenotype.Semantic proximity Read ↗

CpG Island Methylator Phenotype Is a Strong Determinant of Poor Prognosis in NeuroblastomasSemantic proximity Read ↗

Clinical application of the CpG island methylator phenotype to prognostic diagnosis in neuroblastomas.Semantic proximity Read ↗

5-Hydroxymethylcytosine Profiles Are Prognostic of Outcome in Neuroblastoma and Reveal Transcriptional Networks That Correlate With Tumor PhenotypeSemantic proximity Read ↗

Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkersSemantic proximity Read ↗

DNA Methylation Fingerprint of Neuroblastoma Reveals New Biological and Clinical InsightsSemantic proximity Read ↗

Genome wide DNA methylation analysis identifies novel molecular subgroups and predicts survival in neuroblastomaSemantic proximity Read ↗

Clustering of Gene Hypermethylation Associated With Clinical Risk Groups in NeuroblastomaSemantic proximity Read ↗

Epigenetic Deregulation of Protocadherin PCDHGC3 in Pheochromocytomas/Paragangliomas Associated With SDHB MutationsSemantic proximity Read ↗

Quantitative global and gene-specific promoter methylation in relation to biological properties of neuroblastomas.Semantic proximity Read ↗

Marked and independent prognostic significance of the CpG island methylator phenotype in neuroblastomas.Semantic proximity Read ↗

Identification of genes targeted by CpG island methylator phenotype in neuroblastomas, and their possible integrative involvement in poor prognosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.